Herbal medicines from ginkgo leaf extract in the treatment of mild dementia
According to current EU monograph of the Committee on Herbal Medicinal Products of European Medicines Agency (EMA/HMPC) for ginkgo leaf, Ginkgonis folium (Ginkgo biloba, Ginkgoaceae), herbal medicines prepared from refined and quantified dry extract of ginkgo leaf are used for the improvement of (ag...
Main Authors: | , |
---|---|
Format: | Article |
Language: | srp |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia
2020-01-01
|
Series: | Arhiv za farmaciju |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632002081P.pdf |
id |
doaj-6db61d9b9fa04c20829eef7a01b8cb30 |
---|---|
record_format |
Article |
spelling |
doaj-6db61d9b9fa04c20829eef7a01b8cb302021-03-22T20:07:50ZsrpPharmaceutical Association of Serbia, Belgrade, SerbiaArhiv za farmaciju0004-19632217-87672020-01-01702819710.5937/arhfarm2002081P0004-19632002081PHerbal medicines from ginkgo leaf extract in the treatment of mild dementiaPetrović Silvana0https://orcid.org/0000-0003-0787-3077Ušjak Ljuboš1https://orcid.org/0000-0002-0796-393XUniverzitet u Beogradu, Farmaceutski fakultet, Katedra za farmakognoziju, Beograd, SerbiaUniverzitet u Beogradu, Farmaceutski fakultet, Katedra za farmakognoziju, Beograd, SerbiaAccording to current EU monograph of the Committee on Herbal Medicinal Products of European Medicines Agency (EMA/HMPC) for ginkgo leaf, Ginkgonis folium (Ginkgo biloba, Ginkgoaceae), herbal medicines prepared from refined and quantified dry extract of ginkgo leaf are used for the improvement of (age-associated) cognitive impairment and of quality of life in mild dementia. It was demonstrated in clinical trials that long-term use of the extract is effective mainly in patients more than 50 years old. The precise mode of action is not known. According to Ph. Eur., the extract should contain 22.0-27.0% of flavonoids, 2.8-3.4% of ginkgolides A, B and C, and 2.6-3.2% of bilobalide, which are active constituents, and maximum 5 ppm of ginkgolic acids, which are potential allergens. These herbal medicines are characterized by corresponding posology, duration of use, contraindications, special warnings, and precautions for use, interactions and possible undesirable reactions.https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632002081P.pdfginkgo bilobaleaf extractmild dementiaherbal medicinesefficacy and safety |
collection |
DOAJ |
language |
srp |
format |
Article |
sources |
DOAJ |
author |
Petrović Silvana Ušjak Ljuboš |
spellingShingle |
Petrović Silvana Ušjak Ljuboš Herbal medicines from ginkgo leaf extract in the treatment of mild dementia Arhiv za farmaciju ginkgo biloba leaf extract mild dementia herbal medicines efficacy and safety |
author_facet |
Petrović Silvana Ušjak Ljuboš |
author_sort |
Petrović Silvana |
title |
Herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
title_short |
Herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
title_full |
Herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
title_fullStr |
Herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
title_full_unstemmed |
Herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
title_sort |
herbal medicines from ginkgo leaf extract in the treatment of mild dementia |
publisher |
Pharmaceutical Association of Serbia, Belgrade, Serbia |
series |
Arhiv za farmaciju |
issn |
0004-1963 2217-8767 |
publishDate |
2020-01-01 |
description |
According to current EU monograph of the Committee on Herbal Medicinal Products of European Medicines Agency (EMA/HMPC) for ginkgo leaf, Ginkgonis folium (Ginkgo biloba, Ginkgoaceae), herbal medicines prepared from refined and quantified dry extract of ginkgo leaf are used for the improvement of (age-associated) cognitive impairment and of quality of life in mild dementia. It was demonstrated in clinical trials that long-term use of the extract is effective mainly in patients more than 50 years old. The precise mode of action is not known. According to Ph. Eur., the extract should contain 22.0-27.0% of flavonoids, 2.8-3.4% of ginkgolides A, B and C, and 2.6-3.2% of bilobalide, which are active constituents, and maximum 5 ppm of ginkgolic acids, which are potential allergens. These herbal medicines are characterized by corresponding posology, duration of use, contraindications, special warnings, and precautions for use, interactions and possible undesirable reactions. |
topic |
ginkgo biloba leaf extract mild dementia herbal medicines efficacy and safety |
url |
https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2020/0004-19632002081P.pdf |
work_keys_str_mv |
AT petrovicsilvana herbalmedicinesfromginkgoleafextractinthetreatmentofmilddementia AT usjakljubos herbalmedicinesfromginkgoleafextractinthetreatmentofmilddementia |
_version_ |
1724207129470959616 |